ORCHARD THERAPEUTICS PLC.

In News

Kyowa Kirin acquires Orchard Therapeutics for $477.6m - Pharmaceutical Technology

Pharmaceutical Technology - Jan 25, 2024

GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics - GSK

GSK - Apr 12, 2018

Orchard (ORTX) Up 97% on $478M Acquisition Deal With Kyowa Kirin - Yahoo Finance

Yahoo Finance - Oct 06, 2023

Orchard sets out to sell world’s priciest gene therapy - BioPharma Dive

BioPharma Dive - Mar 20, 2024

NICE backs Orchard rare disease drug after further cut to $3.9M list price - BioWorld News

BioWorld News - Feb 04, 2022

£438 million investment for UCL gene therapy spinouts | UCL News - UCL – University College London - UCL | University College London

UCL | University College London - Nov 08, 2018

Orchard Therapeutics hires ex-PTC executive Mark Rothera as new CEO - Fierce Biotech

Fierce Biotech - Aug 10, 2017

Orchard follows buyout with FDA approval of rare disease gene therapy - BioPharma Dive

BioPharma Dive - Mar 19, 2024

Orchard Therapeutics plc (NASDAQ: ORTX) - Share Price - intelligentinvestor.com.au

intelligentinvestor.com.au - Dec 28, 2024

Rare stem cell success gives young girl life outside the bubble - Capitol Weekly

Capitol Weekly - Dec 20, 2023

Tiny U.K. Biotech Takes On Glaxo’s $730,000 Gene Therapy - Bloomberg.com

Bloomberg.com - Mar 06, 2018

Interview: Orchard's Gene Therapies Bear Fruit With $110m Financing - insights.citeline.com

insights.citeline.com - Dec 20, 2017

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment